Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Isuzinaxib by AptaBio Therapeutics for Acute Renal Failure (ARF) (Acute Kidney Injury): Likelihood of Approval
Isuzinaxib is under clinical development by AptaBio Therapeutics and currently in Phase II for Acute Renal Failure (ARF) (Acute Kidney...